Litcius/Paper detail

CircRNA_30032 promotes renal fibrosis in UUO model mice via miRNA-96-5p/HBEGF/KRAS axis

Lei Yi, Kai Ai, Huiling Li, Shuangfa Qiu, Yijian Li, Yinhuai Wang, Xiaozhou Li, Peilin Zheng, Junxiang Chen, Dengke Wu, Xudong Xiang, Xiangping Chai, Yunchang Yuan, Dongshan Zhang

2021Aging28 citationsDOIOpen Access PDF

Abstract

models. CircRNA_30032 expression was significantly increased by 9.15- and 16.6-fold on days 3 and 7, respectively, in the renal tissues of UUO model mice. In TGF-β1-treated BUMPT cells, circRNA_30032 expression was induced by activation of the p38 mitogen-activated protein kinase signaling pathway. Quantitative real-time PCR, western blotting and dual luciferase reporter assays showed that circRNA_30032 mediated TGF-β1-induced and UUO-induced renal fibrosis by sponging miR-96-5p and increasing the expression of profibrotic proteins, including HBEGF, KRAS, collagen I, collagen III and fibronectin. CircRNA_30032 silencing significantly reduced renal fibrosis in UUO model mice by increasing miR-96-5p levels and decreasing levels of HBEGF and KRAS. These results demonstrate that circRNA_30032 promotes renal fibrosis via the miR-96-5p/HBEGF/KRAS axis and suggest that circRNA_30032 is a potential therapeutic target for treatment of renal fibrosis.

Topics & Concepts

KRASmicroRNACancer researchFibrosisMedicineInternal medicineBiologyCancerGeneColorectal cancerGeneticsCircular RNAs in diseasesMicroRNA in disease regulationBiomarkers in Disease Mechanisms